Members of our leadership team hold an average of 21 years experience in clinical research. Together with PharPoint’s founders, they lead our teams in anticipating challenges, providing quality solutions, and staying ahead of clinical trial deadlines.
Moya Hawkins Senior Director of Strategic Consulting
Moya Hawkins has experience managing Phase 1 through Phase 4 clinical trials across both EDC and paper platforms, including global, multilingual Phase 3 and 4 studies.
Her database experience includes serving on EDC steering committees within several companies, application validation, and serving as a point person for the implementation of the transition from paper-based studies to EDC studies.
Ms. Hawkins has experience managing multi-country, emergency use protocol studies with special patient populations, and salvage therapy studies. She has served on a committee for the Society of Clinical Data Management, a non-profit dedicated to the advancement of clinical data management.
Amy Flynt, PhD Senior Director of Biostatistics and Strategic Consulting
Amy Flynt, PhD, joined PharPoint in its inaugural year to grow biostatistics operations.
Prior to PharPoint, her experience includes having provided FDA representation, serving as a DMC statistician, and acting as a statistical consultant.
She’s served as a lead statistician and provided statistical support for Phase 1 through 4 clinical trials, NDA submissions, and industry-sponsored registries.
Jayme Swinson, MS Executive Director of Operations
Jayme Swinson’s experience in the CRO industry includes both statistical analysis and clinical database programming support for Phase 1 to Phase 4 clinical trials as well as patient registries.
He’s led multiple data standardization and warehousing projects, many of which comply with the industry-accepted SDTM format.
Mr. Swinson was one of the original members at PharPoint, and established and led the programming department, defining and refining standard processes across functional areas.
Alycia Olesen, MBA Director of Data Management
Alycia Olesen’s experience includes managing both local and global Phase 1 to 4 clinical trials as well as utilizing multiple EDC platforms.
Throughout her career, she has worked across functional areas to facilitate communication and make improvements in working practices. This includes working closely with database programmers and data managers to develop and implement platform specific eCRF and data validation specifications, improving processes and communications and increasing efficiency within the data management and database programming departments.
Paul Johnson Clinical Operations Strategist
Paul Johnson’s experience includes both working in healthcare as well as in the drug development. Mr. Johnson brings extensive experience as a CRA, clinical project manager and clinical operations manager.
Throughout his career, he has developed and implemented various project management methodologies. This has included study planning, risk management and contingency plans as well as managing the execution of site monitoring, site management, and data collection.
In his previous management roles, Mr. Johnson has recommended and implemented various clinical operations performance and productivity improvements and consistently ensuring sponsor expectations were met.
Julie Robey Director of Clinical Operations
Ms. Robey brings over 20 years of drug discovery and development experience, most recently as Director of Project Management for a small biotech focusing on timeline and vendor management in drug discovery.
Prior to that she held positions of increasing responsibility in clinical development services, strategic development and data management focusing in the areas of Hepatitis C, Hepatitis B, HIV, NASH, liver fibrosis, breast cancer and prostate cancer.
She has managed pre-clinical, Phase 1 – Phase 4 trials of all sizes from 1 site to over 500 sites globally.
Baker Sharpe Director, Data Management
Baker Sharpe holds 13+ years of experience in clinical data management, spanning therapeutic areas including infectious disease, oncology, cardiovascular, and numerous others.
Before joining PharPoint, Ms. Sharpe spent 9 years in roles of increasing responsibility in the data management departments of two large CROs.
Currently, along with ensuring optimal performance of PharPoint’s data management group functions, Ms. Sharpe has worked to continuously train and develop the data management team to increase efficiencies and maintain state-of-the-art data management practices.
Karisa Satterly Director of Business Development
As PharPoint’s Director of Business Development, Karisa Satterly leads initiatives for company growth and helps diversify PharPoint’s pipeline of work. She brings over a decade of experience in the industry to PharPoint.
Ms. Satterly’s experience in clinical research includes working across the biotech, pharma, device, and CRO industries. Prior to PharPoint, Ms. Satterly held various roles of increasing responsibility in the data management industry, including positions in business analytics, marketing, business development, and account management.
Ms. Satterly holds a Bachelors of Business Administration from Texas A&M University. To speak with a representative on PharPoint’s business development team, visit our “Contact Us” page or email us at firstname.lastname@example.org.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.